Duloxetine 1 year on: The long-term outcome of a cohort of women prescribed duloxetine

International Urogynecology Journal

Volumn 19, Issue 7, 2008, Pages 961-964

  Vella, Maria ^a   Duckett, Jonathan ^a   Basu, Maya ^a  

^a MEDWAY MARITIME HOSPITAL   (United Kingdom)

Author keywords

Duloxetine; Persistence; Stress incontinence; Tension free vaginal tape

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DULOXETINE;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; STRESS INCONTINENCE; TENSION FREE VAGINAL TAPE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 44649101912     PISSN: 09373462     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00192-008-0564-4     Document Type: Article

References (13)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A (2002) The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International continence society. Am J Obstet Gynecol 187:116-126
2. Kelleher CJ, Cardozo L, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104:1374-1379
3. Dmochowski R, Miklos JR, Norton PA, Zinner NR, Yalcin I, Bump RC (2003) Duloxetine vs placebo for the treatment of North American women with stress urinary incontinence. J Urol 170:1259-1263
4. Millard RJ, Moore K, Rencken R, Yalcin I, Bump RC (2004) Duloxetine vs placebo in the treatment of stress urinary incontinence: A four continent randomised controlled clinical trial. BJU Int 93:311-318
5. Norton PA, Zinner NR, Yalcin I, Bump RC (2002) Duloxetine vs placebo in the treatment of stress urinary incontinence. Am J Obstet Gynecol 187:40-48
6. Van Kerrebroek P, Abrams P, Lange R, Slack M, Wyndaele JJ, Yalcin I (2004) Duloxetine vs placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG 111:249-257
7. Duckett J, Vella M, Kavalakuntla G, Basu M (2007) Tolerability and efficacy of duloxetine in a non trial situation. BJOG 114:543-547
8. Bent AE, Grousse AE, Hendrix SI, Klutke CG, Monga AK, Yuen CK, Muram D, Yalcin I, Bump RC (2007). Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence. Neurourol Urodyn DOI 10.1002/nau.20471
9. Cardozo L, Drutz HP, Baygani SK, Bump RC (2004) Pharmacological treatment of women awaiting surgery for stress urinary incontinence. Obstet Gynecol 104:511-519
10. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol 104:988-993
11. Robinson D, Anders K, Cardozo L et al (2003) What do women want? Interpretation of the concept of cure. J Pelvic Med Surg 8:273-279
12. Robinson D, Anders K, Cardzozo L, Bidmead J (2007) Outcome measures in urogynaecology: The clinicians' perspective. Int Urogynecol J 18(3):273-279
13. Ward KL, Hilton P, UK and Ireland TVT Trial Group (2004) A prospective multicentre randomised trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence; 2 year follow-up. Am J Obstet Gynecol 190:324-331